Mankind Pharma Ltd share price logo

Mankind Pharma Ltd Share Price

NSE: MANKIND

BSE: 543904

Mid Cap

Healthcare Sector

₹2399.50

+15.50

(+0.65%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Mankind Pharma Ltd Stock Performance

as on November 3, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹2,357.2
    ₹2,404.2
    downward going graph

    1.76%

    Downside

    0.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹2,115.1
    ₹3,054.8
    downward going graph

    11.85%

    Downside

    27.31%

    Upside

    downward going graph

Mankind Pharma Ltd share price movements today

Previous Close
₹2,384.00
Open
₹2,383.30
Volume
2.03L
Upper Circuit
₹2,622.40
Lower Circuit
₹2,145.60
Day's Low - High
₹2,357.2 - ₹2,404.2
52 Week Low - High
₹2,115.1 - ₹3,054.8

Mankind Pharma Ltd Historical Returns

1 Month Return
-2.31 %
3 Month Return
-8.73 %
1 Year Return
-12.14 %
3 Year Return
+ 68.71 %
5 Year Return
+ 68.71 %

Mankind Pharma Ltd Fundamentals

as on November 3, 2025 at 4:01 pm IST

Market Cap

₹99,041.40 Cr

Return on Equity (ROE)

13.89

PE Ratio (TTM)

51.51

Return on capital employed (ROCE)

14.88

Industry PE ratio

41.74

Beta (LTM)

0.63

P/B Ratio

6.83

Dividend Yield

0

PEG Ratio

-21.37

Quarterly Earnings Growth YOY

-18.13

EPS (TTM)

48.74

Sector

Pharmaceuticals

Book Value

347.37

Technical Analysis

Bearish

View Technical Analysis

Mankind Pharma Ltd Stock Valuation

as on November 3, 2025 at 4:01 pm IST

Mankind Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Industry (41.74x)

November 3, 2025

Today (51.51x)

November 3, 2025

Highest (57.89x)

July 14, 2025

LowHigh

Today’s Price to Earnings Ratio: 51.51x

Mankind Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mankind Pharma Ltd image
Mankind Pharma Ltd
BUY99,041.4013.74%0.692,01112,207
Glenmark Pharmaceuticals Ltd image
Glenmark Pharmaceuticals Ltd
BUY53,573.0056.29%0.621,04713,321
Alkem Laboratories Ltd image
Alkem Laboratories Ltd
HOLD67,297.1621.74%0.592,21612,964
Dr Reddys Laboratories Ltd image
Dr Reddys Laboratories Ltd
HOLD99,819.814.23%0.575,72532,643
Glaxosmithkline Pharmaceuticals Ltd image
Glaxosmithkline Pharmaceuticals Ltd
BUY45,448.2518.45%0.569273,749
See all

Analyst Recommendation on Mankind Pharma Ltd Stock

Based on 17 analysts

BUY

76.47%

Buy

11.76%

Hold

11.76%

Sell

Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Mankind Pharma Ltd. Average target price of ₹2798.94

Source: S&P Global Market Intelligence

Mankind Pharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Mankind Pharma Ltd.

What analysts predicted

16.65%UPSIDE

Target Price

₹2798.94

Current Price

₹2399.5

Analyzed by

17 Analysts

High

₹3300

Target

₹2798.94

Low

₹2150

Mankind Pharma Ltd target price ₹2798.94, a slight upside of 16.65% compared to current price of ₹2399.5. According to 17 analysts rating.

Source: S&P Global Market Intelligence

Mankind Pharma Ltd Stock’s Investor Sentiment and Interest

Search interest for Mankind Pharma Ltd Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2% versus previous 30 day period

Mankind Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
2,090.93
2,052.67
2,578.62
2,708.1
2,606.95
2,422.24
2,867.85
3,076.51
3,198.79
3,079.37
3,570.35
Other Income
39.5
50.28
63.35
63.45
74.73
94.56
107.9
112
87.09
253.65
83.05
Total Income
2,130.43
2,102.95
2,641.97
2,771.55
2,681.68
2,516.8
2,975.75
3,188.51
3,285.88
3,333.02
3,653.4
Expenses
1,653.89
1,635.99
1,923.81
2,025.45
2,000.45
1,836.27
2,196.29
2,226.47
2,382.8
2,400.52
2,723.58
Operating Profit
437.04
416.68
654.81
682.65
606.5
585.97
671.56
850.04
815.99
678.85
846.77
Operating Profit Margin %
20.9%
20.3%
25.39%
25.21%
23.26%
24.19%
23.42%
27.63%
25.51%
22.05%
23.72%
Profit Before Interest, Tax and Depreciation
476.54
466.96
718.16
746.1
681.23
680.53
779.46
962.04
903.08
932.5
929.82
Interest
12.76
5.16
6.34
8.62
9.19
9.17
10.84
7.1
220.93
190.54
170.65
Depreciation
84.79
84.52
87.35
96.49
109.72
99.78
102.69
105.62
187.17
230.87
218.68
Profit Before Tax
378.99
377.28
624.47
640.99
562.32
571.58
665.93
849.32
494.98
511.09
540.49
Tax Paid
83.27
83.59
130.28
129.81
102.51
94.99
122.86
190.44
110.46
86.44
95.87
Profit After Tax
295.72
293.7
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
Total Net profit including share of profit / Loss from associate company
295.72
293.7
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
EPS
7.09
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
Actual EPS
7.09
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
Adjusted EPS
7.09
7.13
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
Diluted EPS
7.09
7.13
12.14
12.49
11.31
11.74
13.37
16.28
9.44
10.18
10.6

Mankind Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
5,865.23
6,214.43
7,781.56
8,749.43
10,260.44
12,207.44
Other Income
121.96
182.63
210.48
140.99
296.41
553.56
Total Income
5,987.19
6,397.06
7,992.03
8,890.42
10,556.85
12,761
Expenses
4,428.42
4,566.33
5,792.2
6,848.8
7,746.76
9,189.51
Operating Profit
1,436.81
1,648.1
1,989.36
1,900.63
2,513.68
3,017.93
Operating Profit Margin %
24.5%
26.52%
25.57%
21.72%
24.5%
24.72%
Profit Before Interest, Tax and Depreciation
1,558.77
1,830.73
2,199.83
2,041.63
2,810.09
3,571.49
Interest
21.97
20.15
58.61
44.47
32.75
429.41
Depreciation
99.06
118.97
166.62
325.92
378.42
621.22
Profit Before Tax
1,437.74
1,691.61
1,974.6
1,671.24
2,398.92
2,520.86
Tax Paid
381.59
398.58
521.64
361.57
457.15
509.74
Profit After Tax
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
Total Net profit including share of profit / Loss from associate company
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
EPS
26.36
32.28
35.78
32
47.75
49.28
Actual EPS
26.36
32.28
35.78
32
47.75
49.28
Adjusted EPS
26.36
32.28
35.78
32
47.75
49.28
Diluted EPS
26.36
32.28
35.78
32
47.68
49.19

Mankind Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,069.71
1,137.24
919.78
1,813.3
2,152.44
2,413.38
Cash Flow from Investing Activities
-435.54
-1,221.85
-1,368.67
-1,051.82
-2,080.52
-12,624.07
Cash Flow from Financing Activities
-530.74
-7.81
604.62
-739.72
5.27
10,232.56
Net Cash Flow
103.42
-92.4
155.73
21.76
77.19
21.87

Mankind Pharma Ltd Stock Shareholding Pattern

Numbers in percentages

Mar 2023
May 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
76.5%
76.5%
76.5%
76.5%
76.5%
74.88%
74.87%
74.87%
72.71%
72.7%
72.68%
72.67%
DII
2.64%
2.64%
4.64%
4.39%
9.49%
11.14%
9.95%
9.9%
11.06%
11.48%
11.5%
11.92%
FII
0%
0%
0%
0%
0%
9.87%
11.58%
12.37%
13.34%
12.92%
13.07%
12.84%
Public
18.25%
18.25%
14.68%
14.76%
6.97%
4.11%
3.61%
2.86%
2.9%
2.9%
2.75%
2.57%
Total Outstanding Shares
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,06,35,138
40,06,44,138
41,25,66,899
41,25,78,527
41,27,28,748
41,27,58,490
Total Shareholders
4,02,322
4,02,322
1,31,918
1,34,731
1,27,449
1,35,116
1,53,450
1,63,854
1,71,281
1,80,597
1,79,549
1,70,347

Mutual Funds that own Mankind Pharma Ltd Stock

Check out the Mutual Funds with significant holdings in Mankind Pharma Ltd.

Mankind Pharma Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Mankind Pharma Ltd.

  • Mankind Pharma Ltd Earnings Results

    Mankind Pharma Ltd’s net profit fell -18.3% since last year same period to ₹438.32Cr in the Q1 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated 4.17% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Mankind Pharma Ltd Dividends July,2025

    In the quarter ending June 2025, Mankind Pharma Ltd has declared dividend of ₹1.00 per share on 31 Jul 2025 - translating a dividend yield of 0.04%.

    Read More about Dividends

Indices Featuring Mankind Pharma Ltd Stock

Check stock indices that include Mankind Pharma Ltd.

Nifty Midcap 50

₹17,135.65

0.76 (▲129.35%)

BSE Healthcare

₹45,036.92

1.14 (▲507.15%)

BSE 200

₹11,713.00

0.36 (▲41.74%)

Nifty Midcap 150

₹22,216.10

0.77 (▲170.15%)

S&P BSE 250 LargeMidCap

₹11,115.11

0.35 (▲38.33%)

Nifty LargeMidcap 250

₹16,755.20

0.53 (▲88.45%)

NIFTY PHARMA

₹22,442.60

1.2 (▲267.2%)

Nifty Healthcare

₹14,836.05

0.97 (▲142.75%)

Nifty MidSmallcap 400

₹20,492.65

0.75 (▲151.7%)

Nifty Midcap Sel

₹13,589.05

0.9 (▲121.2%)

Nifty 200

₹14,416.35

0.38 (▲54.05%)

S&P BSE Largecap

₹9,935.33

0.32 (▲31.32%)

Nifty Midcap 100

₹60,287.40

0.77 (▲461.5%)

Nifty 500

₹23,810.70

0.42 (▲100.3%)

S&P BSE 100 LargeCap TMC

₹9,535.38

0.28 (▲27.09%)

BSE 500

₹37,361.96

0.4 (▲147.92%)

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 2.51K Cr → 3.65K Cr (in ₹), with an average increase of 7.1% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 380.23 Cr → 438.32 Cr (in ₹), with an average increase of 6.8% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 7.34% to 7.78% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, MANKIND stock has moved down by -9.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 2.75% to 2.57% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 13.07% to 12.84% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.68% to 72.67% in Sep 2025 quarter

Mankind Pharma Ltd Stock Futures & Options Contracts

View the latest movement in Mankind Pharma Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

Mankind Pharma Ltd Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 25 Nov ₹2500 Call
November 25, 2025
₹2500
₹40.55
10.2
33.61%
MANKIND 25 Nov ₹2400 Call
November 25, 2025
₹2400
₹82
17.1
26.35%
MANKIND 25 Nov ₹2450 Call
November 25, 2025
₹2450
₹58
13.45
30.19%
MANKIND 25 Nov ₹2600 Call
November 25, 2025
₹2600
₹17.75
4.05
29.56%

Mankind Pharma Ltd Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 25 Nov Fut
November 25, 2025
-
₹2417.1
32.9
1.38%
MANKIND 30 Dec Fut
December 30, 2025
-
₹2426
29.72
1.24%
MANKIND 27 Jan Fut
January 27, 2026
-
₹2439
23.43
0.97%

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹3,570.35Cr as on June 2025 (Q1 FY26)
Net Profit: ₹444.62Cr as on June 2025 (Q1 FY26)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

FAQs

What is Mankind Pharma Ltd share price today?

Mankind Pharma Ltd share price today stands at ₹2399.5 as on at the close of the market. Mankind Pharma Ltd share today touched a day high of ₹2404.2 and a low of ₹2357.2.

What is the 52 week high and 52 week low range for Mankind Pharma Ltd share?

Mankind Pharma Ltd touched a 52 week high of ₹3054.8 and a 52 week low of ₹2115.1. Mankind Pharma Ltd share price today i.e. is closed at ₹2399.5, which is -21.45% down from its 52 week high and 13.45% up from its 52 week low.

What is Mankind Pharma Ltd's market capitalisation today?

Mankind Pharma Ltd market capitalisation is ₹99,041.40 Cr as on .

How to buy Mankind Pharma Ltd shares?

To buy Mankind Pharma Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mankind Pharma Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mankind Pharma Ltd trading volume today?

Mankind Pharma Ltd trading volume is 2.03L as on . This means that 2.03L shares of Mankind Pharma Ltd were bought and sold on the stock market during today's trading session.